Oruka Therapeutics, Inc. Common Stock (ORKA) Financials
Key financial figures for Oruka Therapeutics, Inc. Common Stock (Q1 2026).
- Revenue
- $0
- Net Income
- -$32M
- EPS
- $-0.46
- Total Assets
- $504M
- Operating Cash Flow
- -$24M
Full income statement, balance sheet, and cash flow for Oruka Therapeutics, Inc. Common Stock on SentiSense.